End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
6.31
CNY
|
-1.87%
|
|
-2.47%
|
+36.88%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
64,331
|
53,859
|
49,371
|
54,947
|
46,796
|
84,609
|
84,609
|
-
|
Enterprise Value (EV)
1 |
64,331
|
53,859
|
49,371
|
54,947
|
46,796
|
84,609
|
84,609
|
84,609
|
P/E ratio
|
15.8
x
|
12.4
x
|
8.07
x
|
-67.3
x
|
-24.9
x
|
11.4
x
|
9.89
x
|
8.99
x
|
Yield
|
3.81%
|
5.05%
|
6.2%
|
-
|
-
|
3.17%
|
4.28%
|
4.91%
|
Capitalization / Revenue
|
1.14
x
|
0.99
x
|
0.96
x
|
0.77
x
|
0.58
x
|
1
x
|
0.97
x
|
0.95
x
|
EV / Revenue
|
1.14
x
|
0.99
x
|
0.96
x
|
0.77
x
|
0.58
x
|
1
x
|
0.97
x
|
0.95
x
|
EV / EBITDA
|
5.75
x
|
4.68
x
|
3.65
x
|
19.3
x
|
18.2
x
|
5.46
x
|
4.88
x
|
4.51
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-9,353,615
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-0%
|
-
|
-
|
-
|
Price to Book
|
1.05
x
|
0.84
x
|
0.73
x
|
0.86
x
|
0.76
x
|
1.23
x
|
1.14
x
|
1.06
x
|
Nbr of stocks (in thousands)
|
13,600,690
|
13,600,690
|
13,600,690
|
13,600,690
|
13,408,733
|
13,408,733
|
13,408,733
|
-
|
Reference price
2 |
4.730
|
3.960
|
3.630
|
4.040
|
3.490
|
6.310
|
6.310
|
6.310
|
Announcement Date
|
4/15/19
|
4/27/20
|
4/27/21
|
4/28/22
|
4/13/23
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
56,634
|
54,371
|
51,684
|
71,073
|
80,195
|
84,476
|
86,847
|
89,482
|
EBITDA
1 |
11,181
|
11,505
|
13,524
|
2,854
|
2,576
|
15,499
|
17,326
|
18,765
|
EBIT
1 |
5,184
|
5,806
|
7,827
|
-2,921
|
-3,172
|
9,539
|
12,215
|
13,329
|
Operating Margin
|
9.15%
|
10.68%
|
15.14%
|
-4.11%
|
-3.96%
|
11.29%
|
14.07%
|
14.9%
|
Earnings before Tax (EBT)
1 |
5,012
|
5,777
|
7,821
|
-2,828
|
-3,094
|
9,601
|
12,283
|
13,397
|
Net income
1 |
4,036
|
4,293
|
6,086
|
-855.2
|
-1,822
|
7,402
|
8,578
|
9,415
|
Net margin
|
7.13%
|
7.9%
|
11.78%
|
-1.2%
|
-2.27%
|
8.76%
|
9.88%
|
10.52%
|
EPS
2 |
0.3000
|
0.3200
|
0.4500
|
-0.0600
|
-0.1400
|
0.5517
|
0.6383
|
0.7017
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-5,003
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-6.24%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1800
|
0.2000
|
0.2250
|
-
|
-
|
0.2000
|
0.2700
|
0.3100
|
Announcement Date
|
4/15/19
|
4/27/20
|
4/27/21
|
4/28/22
|
4/13/23
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q2
|
2023 Q3
|
---|
Net sales
|
-
|
-
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
1 |
1,768
|
3,184
|
Net margin
|
-
|
-
|
EPS
|
0.1300
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
8/29/23
|
10/27/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-5,003
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.64%
|
6.85%
|
9.22%
|
-1.3%
|
-2.91%
|
10.8%
|
11.6%
|
11.9%
|
ROA (Net income/ Total Assets)
|
3.63%
|
3.89%
|
5.4%
|
-2.14%
|
-
|
4.52%
|
5.82%
|
6.15%
|
Assets
1 |
111,299
|
110,333
|
112,751
|
39,964
|
-
|
163,768
|
147,507
|
153,210
|
Book Value Per Share
2 |
4.500
|
4.720
|
4.990
|
4.700
|
4.570
|
5.120
|
5.550
|
5.960
|
Cash Flow per Share
2 |
0.5000
|
0.6700
|
0.7400
|
0.0600
|
0.0200
|
0.8200
|
0.9800
|
1.110
|
Capex
1 |
2,076
|
1,753
|
3,179
|
4,649
|
5,227
|
15,227
|
6,704
|
8,618
|
Capex / Sales
|
3.67%
|
3.22%
|
6.15%
|
6.54%
|
6.52%
|
18.03%
|
7.72%
|
9.63%
|
Announcement Date
|
4/15/19
|
4/27/20
|
4/27/21
|
4/28/22
|
4/13/23
|
-
|
-
|
-
|
Last Close Price
6.31
CNY Average target price
5.917
CNY Spread / Average Target -6.23% Consensus |
1st Jan change
|
Capi.
|
---|
| +36.88% | 11.68B | | +18.36% | 17.24B | | -10.11% | 12.67B | | +46.81% | 12.56B | | +20.23% | 5.32B | | -1.85% | 4.63B | | +26.33% | 4.33B | | -1.55% | 3.64B | | +9.41% | 3.5B | | +15.54% | 3.16B |
Fossil Fuel IPPs
|